🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a multicenter, open-label study to evaluate the dose of Orenitram®...
Status
Completed
Location
University of California San Francisco - Fresno
Start Date
2019-01-31
Trial ID
NCT03497689
Treatments Being Tested
This study was an international, multi-center, randomized, double-blind, pl...
Status
Completed
Location
University of Alabama-Birmingham
Start Date
2006-10
Trial ID
NCT00325442
Treatments Being Tested
The goal of this clinical trial is to evaluate whether inhaled Treprostinil...
Status
Recruiting
Location
Duke Asthma Allergy and Airway Center
Start Date
2025-09-29
Trial ID
NCT07037836
Treatments Being Tested
The purpose of this study is to see how inhaled treprostinil sodium (Tyvaso...
Status
Terminated
Location
University of Florida, Jacksonville
Start Date
2011-11
Trial ID
NCT01494896
A surveillance of respiratory tract related adverse events in patients trea...
Status
Completed
Location
Cardiovascular Associates, P.C.
Start Date
2010-12
Trial ID
NCT01266265
Abstract This is a multi-center, open-label pharmacokinetic (PK) study exa...
Status
Completed
Location
Lucille Packard Children's Hospital
Start Date
2013-10
Trial ID
NCT02318186
The primary objective of this study is to assess the effect of early and ra...
Status
Active Not Recruiting
Location
Banner University Medical Center (University of Arizona)
Start Date
2022-10-20
Trial ID
NCT05203510
Treatments Being Tested
This study is an international, multi-center, randomized, double-blind, pla...
Status
Withdrawn
Location
University of Alabama Birmingham
Start Date
2008-12
Trial ID
NCT00760916
Treatments Being Tested
Pulmonary Arterial Hypertension (PAH) is a serious condition that puts stra...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-31
Trial ID
NCT07177703
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
ARG003
Start Date
2023-05-11
Trial ID
NCT05649722
Treatments Being Tested